Macrophage migration inhibitory factor

Critical Care Medicine

Volumn 30, Issue 1 SUPPL. B, 2002, Pages

  Baugh, John A ^a   Bucala, Richard ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

Acute respiratory distress syndrome; Glucocorticoids; Inflammation; Macrophage migration inhibitory factor; Sepsis

Indexed keywords

GAMMA INTERFERON; GLUCOCORTICOID; I KAPPA B; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

CELLULAR DISTRIBUTION; CONFERENCE PAPER; CYTOKINE RELEASE; ENZYME ACTIVITY; IMMUNE SYSTEM; INFLAMMATION; LUNG INJURY; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN STRUCTURE; RESPIRATORY DISTRESS SYNDROME; SEPSIS; SEQUENCE ANALYSIS; TISSUE DISTRIBUTION;

EID: 0036162165     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200201001-00004     Document Type: Conference Paper

References (96)

1. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity
2. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction
3. Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells
4. Alterations of macrophage functions by mediators from lymphocytes
5. Characterization of a lymphocyte factor which alters macrophage functions
6. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor
7. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia
8. MIF as a glucocorticoid-induced modulator of cytokine production
9. Localization of macrophage-migration inhibitory factor (MIF) to secretory granules within the corticotropic and thyrotropic cells of the pituitary-gland
10. MIF rediscovered: Cytokine, pituitary hormone, and glucocorticoid- induced regulator of the immune response
11. Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis
12. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: Interaction with glucocorticoids
13. Assembly of the ER to Golgi SNARE complex requires Usolp
14. Crystal structure of the macrophage migration inhibitory factor from rat liver
15. Crystal structure at 2.6-angstrom resolution of human macrophage migration inhibitory factor
16. Regulation of macrophage migration inhibitory factor and thiol-specific antioxidant protein PAG by direct interaction
17. Crystallization and preliminary X-ray analysis of human D-dopachrome tautomerase
18. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction
19. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase
20. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase
21. Cloning and sequencing of a cDNA encoding rat D-dopachrome tautomerase
22. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor
23. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor
24. Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor
25. Enzymatic ketonization of 2-hydroxymuconate: Specificity and mechanism investigated by the crystal structures of two isomerases
26. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity
27. Macrophage migration inhibitory factor: Cytokine, hormone, or enzyme?
28. Determination of p-hydroxyphenylpyruvate, p-hydroxyphenyllactate and tyrosine in normal human plasma by gas chromatography-mass spectrometry isotope-dilution assay
29. On the reactivity and ionization of the active site cysteine residues of Escherichia coli thioredoxin
30. The role of the thiol/disulfide centers and peptide binding site in the chaperone and anti-chaperone activities of protein disulfide isomerase
31. Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration
32. Macrophage is an important and previously unrecognized source of macrophage-migration inhibitory factor
33. Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3′,5′- monophosphate responsive element-binding protein CREB in pituitary cells
34. Purification and characterization of macrophage migration inhibitory factor as a secretory protein from rat epididymis: Evidences for alternative release and transfer to spermatozoa
35. A cytoskeleton-related gene, uso1, is required for intracellular protein transport in Saccharomyces cerevisiae
36. The role of the tethering proteins p115 and GM130 in transport through the Golgi apparatus in vivo
37. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
38. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria
39. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection
40. Regulation of the CTL response by macrophage migration inhibitory factor
41. + T cell death
42. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: Possible role in the pathogenesis of malarial anemia
43. Migration inhibitory factor expression in experimentally induced endotoxemia
44. Protection from septic shock by neutralization of macrophage migration inhibitory factor
45. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis
46. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
47. MIF is an essential mediator of T-cell activation, is released from T-cells by glucocorticoids, and overrides glucocorticoid suppression of T-cell proliferation
48. Macrophage migration inhibitory factor and innate immune responses to bacterial infections
49. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness
50. Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF)
51. Role of selectins in development of adult respiratory distress syndrome
52. Pulmonary accumulation of polymorphonuclear leukocytes in the adult respiratory distress syndrome
53. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation
54. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome
55. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation
56. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF): Potential role in asthma
57. The eosinophil and its role in asthma
58. Eosinophils and eosinophil-associated cytokines in allergic inflammation
59. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor
60. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle
61. A proinflammatory cytokine inhibits p53 tumor suppressor activity
62. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): Regulatory role in cell proliferation and glucocorticoid action
63. Purification and characterization of the cytokine macrophage- migration inhibitory factor (MIF)
64. Macrophage migration inhibitory factor upregulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis
65. Macrophage migration inhibitory factor increases MMP-2 activity in DU-145 prostate cells
66. Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids
67. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling
68. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor
69. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
70. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell
71. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids
72. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis
73. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha
74. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
75. Purification, bioactivity, and secondary structure-analysis of mouse and human macrophage-migration inhibitory factor (MIF)
76. Regulation of macrophage gene expression by T-cell-derived lymphokines
77. Apoptosis in sepsis: A new target for therapeutic exploration
78. Inducible macrophage apoptosis following sepsis is mediated by cysteine protease activation and nitric oxide release
79. Is sepsis-induced apoptosis associated with macrophage dysfunction?
80. Characterization of gene expression in resting and activated mast cells
81. De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis
82. Macrophage migration inhibitory factor expression in human renal allograft rejection
83. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney
84. Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivo
85. MIF expression in the rat brain: Implications for neuronal function
86. Presence of macrophage migration inhibitory factor (MIF) in ependyma, astrocytes and neurons in the bovine brain
87. Augmented expression of macrophage migration inhibitory factor (MIF) in the telencephalon of the developing rat brain
88. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma
89. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis
90. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion
91. Macrophage migration inhibitory factor production by Leydig cells: Evidence for a role in the regulation of testicular function
92. Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth
93. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction
94. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type ii-induced arthritis in mice
95. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis
96. Macrophage migration inhibitory factor (MIF): A previously unrecognized kidney-derived cytokine which participates in local macrophage accumulation and proliferation in the progression of rat anti-gbm glomerulonephritis